CClinicalTrials.gg
CompletedNCT00026559Updated Jan 9, 2024Results posted

Effects of Arousal and Stress in Anxiety

An interventional study of Shock Device and Auditory Startle Device in Healthy Volunteers, sponsored by National Institute of Mental Health (NIMH). Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-09.

Sponsored by National Institute of Mental Health (NIMH) · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2001, registered Nov 2001).
Phase
Not applicable
Study type
Interventional
Enrollment
1,418
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study has several parts. One part will examine the influence of factors such as personality and past experience on reactions to unpleasant stimuli. Others will examine the effect of personality and emotional and attentional states on learning and memory.

When confronted with fearful or unpleasant events, people can develop fear of specific cues that were associated with these events as well as to the environmental context in which the events occurred via a process called classical conditioning. Classical conditioning has been used to model anxiety disorders, but the relationship between stress and anxiety and conditioned responses remains unclear. This study will examine the relationship between cued conditioning and context conditioning . This study will also explore the acquisition and retention of different types of motor, emotional, and cognitive associative processes during various tasks that range from mildly arousing to stressful.

Read the detailed description

Objective: Fear and anxiety are adaptive responses to different types of threats. Fear is a short-duration response evoked by explicit threat cues and anxiety a more sustained state of apprehension evoked by unpredictable threat. This protocol studied fear using Pavlovian fear conditioning in two studies. Studies 1 and 3. Study 2 focused on anxiety. Studies 1 and 3 will be discontinued to focus uniquely on the study of anxiety. Specifically, we will examine the interactions between anxiety induced experimentally using verbal threat and cognitive processes. We will seek to 1) characterize the effect of anxiety on key cognitive processes including working memory and attention control and 2) examine the extent to which performance of cognitive tasks distract from anxiety.

Study population: This more-than-minimal-risk protocol will test medically and psychiatrically healthy volunteers aged 18-50. Pregnant or nursing women will be excluded.

Method: Fear and anxiety will be measured using the startle reflex to brief and loud sounds. Fear conditioning will be assessed using shock as unconditioned stimulus. Cognitive performance will be examined during periods of unpredictable shock anticipation.

Outcome measures: The study will include cognitive performance and measure of aversive states, primarily the startle reflex.

02

Conditions studied

  • Healthy Volunteers

Keywords

  • Classical Conditioning
  • Fear Conditioning
  • Stress
  • Learning
  • Normal Volunteers
  • Healthy Volunteer
  • Normal Control
03

In context

Lead sponsor

National Institute of Mental Health (NIMH) is the lead sponsor of 359 studies on the registry; 46 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 24 (96%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males and females
  • Age 18-50

Exclusion criteria

EXCLUSION CRITERIA:

  • Pregnancy
  • Any current ongoing medical illness
  • Current Axis I disorders
  • Past significant psychiatric disorders (e.g., psychotic disorders) according to Diagnostic and Statistical Manual (DSM)-IV
  • Current alcohol or substance abuse according to DSM-IV criteria
  • History of alcohol or substance dependence based on DSM-IV criteria within 6 months prior to screening
  • Current psychotropic medication use
  • Current or past organic central nervous system disorders, including but not limited to seizure disorder or neurological symptoms of the wrist and arms (e.g., carpal tunnel syndrome). The latter exclusion is for shock studies only.
  • Positive urine toxicology screen
  • Employees of National Institute of Mental Health (NIMH) or an immediate family member of a NIMH employee.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,418 participants (actual)

Study arms

  • Experimental
    Healthy volunteers

    Sub-study A: Working memory task / Participant performed a working memory task in two conditions, under threat of shock and in safety and asked to remember verbal and nonverbal stimuli from the current stimulus on the screen (N-back task) Sub-study C: Sustained attention to response task (SART) / participant was presented with stimuli and either initiated a response (i.e. "go") or inhibited their response (i.e. "stop") based on what stimuli were presented Sub-study D: Stroop task/ In the classic Stroop test, the name of a color is printed in a color that conflicts or does not conflict with the word. In the emotional Stroop, the words emotional words. The participant's task was to name the color of the word Pilot studies / (1) Shocks were delivered via electrodes located on the forearm or fingers while participant performed a working memory or vigilance task or (2) Subject performed cognitive tasks during alternating safe and threat periods

    Device: Shock Device · Device: Auditory Startle Device

Interventions

  • DeviceShock Device

    Shock Device

  • DeviceAuditory Startle Device

    Auditory Startle Device

06

What researchers measure

Primary outcomes

  1. Go Correct Hits Followed by Button Press

    Subjects participated in go/no go (GNG) task condition during periods of threat of shocks and periods of safety when no shock could be administered. During the GNG stimuli were presented on a monitor. In the GNG task, participants were asked to respond to frequent 'go' stimuli ('=') by pressing the '2' on the keypad of a computer keyboard and to withhold their response to infrequent 'nogo' stimuli ('O'). Stimuli were randomly distributed. A correct go hit was a response recorded during these 2000 millisecond (ms) to a go trial. Similarly, a correct nogo omission was a no response during the same period to a nogo trial. Performance was determined for each condition (threat, safe) and trial type (go, nogo) by dividing the number of correct response by the total number of each trial type.

    Time frame: 250 ms at a rate of one every 2000 ms

  2. Nogo Trials Followed by no Button Press

    Subjects participated in go/no go (GNG) task condition during periods of threat of shocks and periods of safety when no shock could be administered. During the GNG stimuli were presented on a monitor. In the GNG task, participants were asked to respond to frequent 'go' stimuli ('=') by pressing the '2' on the keypad of a computer keyboard and to withhold their response to infrequent 'nogo' stimuli ('O'). Stimuli were randomly distributed. A correct go hit was a response recorded during these 2000 millisecond (ms) to a go trial. Similarly, a correct nogo omission was a no response during the same period to a nogo trial. Performance was determined for each condition (threat, safe) and trial type (go, nogo) by dividing the number of correct response by the total number of each trial type.

    Time frame: 250 ms at a rate of one every 2000 ms

  3. Correct-go Reaction Time (RT)

    Correct go responses were go trials followed by button press. Mean reaction time (RT) was calculated for correct-go to evaluate speed-accuracy trade-off.

    Time frame: 2000 ms during trial

  4. Response to Startle Reflex

    The startle reflex was elicited with a 103-decibel (dB) white noise (40-ms duration) delivered via headphone. The eyeblink component of the startle reflex was recorded binaurally with two AgCl electrodes placed under the left eye. The peak startle/eyeblink reflex magnitude was determined in the 20-100 ms timeframe. The shock was administered either on the left wrist or on the left middle and ring fingers, depending on where the desired intensity was reached. Startle stimuli were delivered between two go trials and go trials that followed a startle stimulus were not included in the analysis. A shock was delivered in two of the four threat blocks in each sequence, just prior to the last go trial, which was not included in the analysis (for a total of 4 shocks). Shock could be administered only in the threat condition and never in the safe condition. The results were analyzed using a Condition (safe, threat) x Task (task, no task) repeated ANOVA.

    Time frame: 20-100 ms window following the onset of the startle stimulus

  5. Subjective Measures of Level of Anxiety

    Subjects retrospectively rated their level of anxiety using a scale of 1-10 where 1 = "not at all anxious" and 10 = "extremely anxious" at the end of each block of a sequence for a total of eight blocks. A block was defined as a combination of a condition (safe or threat) and a task (task or no task). The results were analyzed using a Condition (safe, threat) x Task (task, no task) repeated ANOVA.

    Time frame: Every 100 sec repeated 8 times

Secondary outcomes

  1. Measure of Attention Control

    Subjects completed the Attention Control Scale (ACS) prior to start of the study. The ACS is a 20-item self-report scale that measures attentional focusing (9 items) and attentional shifting (11 items) rated on a four-point likert scale from "1 - almost never" to "4 - always" with total score range of 20 to 80. Higher score on ACS reflect better ability to direct and maintain attention.

    Time frame: 1-3 weeks before start of study

  2. Measure of Level of Anxiety

    The level of anxiety was assessed using the Trait Anxiety Inventory questionnaire. The Trait Anxiety Scale (T-Anxiety) evaluates relatively stable aspects of "anxiety proneness", including general states of calmness, confidence, and security. The Trait Anxiety Scale has 20 items. All items are rated on a 4-point scale: 1 = almost never, 2 = sometimes, 3 = often, and 4 = almost always.. The scale has a minimum score of 20 and a maximum score of 80. Higher score indicates greater anxiety. Trait Anxiety score was measured prior to start of the study.

    Time frame: 1-3 weeks before start of study

07

Results

Posted Jan 9, 2024
Limitations and caveats
This protocol was a series of sub-studies using sample subjects which explains the low numbers of participants per study.

Participant flow

Healthy Volunteers
Participant flow — Healthy Volunteers
MilestoneHealthy Volunteers
Started1418
Completed1418
Not completed0
Working Memory Task
Participant flow — Working Memory Task
MilestoneHealthy Volunteers
Started115
Completed115
Not completed0
Sustained Attention to Response Task
Participant flow — Sustained Attention to Response Task
MilestoneHealthy Volunteers
Started61
Completed61
Not completed0
Stroop Task
Participant flow — Stroop Task
MilestoneHealthy Volunteers
Started69
Completed69
Not completed0
Pilot Studies
Participant flow — Pilot Studies
MilestoneHealthy Volunteers
Started1210
Completed1210
Not completed0

Outcome measures

PrimaryGo Correct Hits Followed by Button Press

Subjects participated in go/no go (GNG) task condition during periods of threat of shocks and periods of safety when no shock could be administered. During the GNG stimuli were presented on a monitor. In the GNG task, participants were asked to respond to frequent 'go' stimuli ('=') by pressing the '2' on the keypad of a computer keyboard and to withhold their response to infrequent 'nogo' stimuli ('O'). Stimuli were randomly distributed. A correct go hit was a response recorded during these 2000 millisecond (ms) to a go trial. Similarly, a correct nogo omission was a no response during the same period to a nogo trial. Performance was determined for each condition (threat, safe) and trial type (go, nogo) by dividing the number of correct response by the total number of each trial type.

Time frame:
250 ms at a rate of one every 2000 ms
Reported as:
Mean · Percentage of correct responses
Go Correct Hits Followed by Button Press
Percentage of correct responsesHealthy Volunteers
Safe Condition90.9 (88.6 to 93.1)
Threat Condition91.6 (89.2 to 94)
PrimaryNogo Trials Followed by no Button Press

Subjects participated in go/no go (GNG) task condition during periods of threat of shocks and periods of safety when no shock could be administered. During the GNG stimuli were presented on a monitor. In the GNG task, participants were asked to respond to frequent 'go' stimuli ('=') by pressing the '2' on the keypad of a computer keyboard and to withhold their response to infrequent 'nogo' stimuli ('O'). Stimuli were randomly distributed. A correct go hit was a response recorded during these 2000 millisecond (ms) to a go trial. Similarly, a correct nogo omission was a no response during the same period to a nogo trial. Performance was determined for each condition (threat, safe) and trial type (go, nogo) by dividing the number of correct response by the total number of each trial type.

Time frame:
250 ms at a rate of one every 2000 ms
Reported as:
Mean · Percentage of correct responses
Nogo Trials Followed by no Button Press
Percentage of correct responsesHealthy Volunteers
Safe Condition74.4 (70.8 to 78.6)
Threat Condition81.2 (76.7 to 85.7)
PrimaryCorrect-go Reaction Time (RT)

Correct go responses were go trials followed by button press. Mean reaction time (RT) was calculated for correct-go to evaluate speed-accuracy trade-off.

Time frame:
2000 ms during trial
Reported as:
Mean · millisecond
Correct-go Reaction Time (RT)
millisecondHealthy Volunteers
Safe Condition358.5 (339.1 to 377.9)
Threat Condition349.3 (331 to 367.5)
PrimaryResponse to Startle Reflex

The startle reflex was elicited with a 103-decibel (dB) white noise (40-ms duration) delivered via headphone. The eyeblink component of the startle reflex was recorded binaurally with two AgCl electrodes placed under the left eye. The peak startle/eyeblink reflex magnitude was determined in the 20-100 ms timeframe. The shock was administered either on the left wrist or on the left middle and ring fingers, depending on where the desired intensity was reached. Startle stimuli were delivered between two go trials and go trials that followed a startle stimulus were not included in the analysis. A shock was delivered in two of the four threat blocks in each sequence, just prior to the last go trial, which was not included in the analysis (for a total of 4 shocks). Shock could be administered only in the threat condition and never in the safe condition. The results were analyzed using a Condition (safe, threat) x Task (task, no task) repeated ANOVA.

Time frame:
20-100 ms window following the onset of the startle stimulus
Reported as:
Mean · milliseconds
Response to Startle Reflex
millisecondsHealthy Volunteers
No Task - Safe condition44.2 (41.9 to 46.4)
No Task - Threat condition57.5 (55 to 59.5)
Task - Safe condition42.4 (41 to 43.9)
Task - Threat condition53 (50.4 to 55.5)
PrimarySubjective Measures of Level of Anxiety

Subjects retrospectively rated their level of anxiety using a scale of 1-10 where 1 = "not at all anxious" and 10 = "extremely anxious" at the end of each block of a sequence for a total of eight blocks. A block was defined as a combination of a condition (safe or threat) and a task (task or no task). The results were analyzed using a Condition (safe, threat) x Task (task, no task) repeated ANOVA.

Time frame:
Every 100 sec repeated 8 times
Reported as:
Mean · Units on a scale
Subjective Measures of Level of Anxiety
Units on a scaleHealthy Volunteers
No Task - Safe Condition1.6 (1.2 to 1.8)
No Task - Threat Condition3.4 (2.7 to 4.2)
Task - Safe Condition1.6 (1.4 to 1.9)
Task - Threat Condition3.6 (2.9 to 4.3)
SecondaryMeasure of Attention Control

Subjects completed the Attention Control Scale (ACS) prior to start of the study. The ACS is a 20-item self-report scale that measures attentional focusing (9 items) and attentional shifting (11 items) rated on a four-point likert scale from "1 - almost never" to "4 - always" with total score range of 20 to 80. Higher score on ACS reflect better ability to direct and maintain attention.

Time frame:
1-3 weeks before start of study
Reported as:
Mean · Units on a scale
Measure of Attention Control
Units on a scaleHealthy Volunteers
Measure of Attention Control59.9 ± 0.9
SecondaryMeasure of Level of Anxiety

The level of anxiety was assessed using the Trait Anxiety Inventory questionnaire. The Trait Anxiety Scale (T-Anxiety) evaluates relatively stable aspects of "anxiety proneness", including general states of calmness, confidence, and security. The Trait Anxiety Scale has 20 items. All items are rated on a 4-point scale: 1 = almost never, 2 = sometimes, 3 = often, and 4 = almost always.. The scale has a minimum score of 20 and a maximum score of 80. Higher score indicates greater anxiety. Trait Anxiety score was measured prior to start of the study.

Time frame:
1-3 weeks before start of study
Reported as:
Mean · Units on a scale
Measure of Level of Anxiety
Units on a scaleHealthy Volunteers
Measure of Level of Anxiety28 ± 0.8

Adverse events

Collected over Up to four hours in a single day visit. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Sub-study A: Working Memory Task0/115 (0%)0/115 (0%)0/115 (0%)
Sub-study C: Sustained Attention to Response Task (SART)0/61 (0%)0/61 (0%)0/61 (0%)
Sub-study D: Stroop Task0/69 (0%)0/69 (0%)0/69 (0%)
Pilot Studies0/1,210 (0%)0/1,210 (0%)0/1,210 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Sub-study A: Working Memory TaskSub-study C: Sustained Attention to Response Task (SART)Sub-study D: Stroop TaskPilot StudiesTotal
Healthy volunteers — <=18 years00000
Healthy volunteers — Between 18 and 65 years115543912101418
Healthy volunteers — >=65 years00000
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Sub-study A: Working Memory TaskSub-study C: Sustained Attention to Response Task (SART)Sub-study D: Stroop TaskPilot StudiesTotal
Healthy volunteers — Female683826655787
Healthy volunteers — Male471613554630
Healthy volunteers — Unknown00011
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Sub-study A: Working Memory TaskSub-study C: Sustained Attention to Response Task (SART)Sub-study D: Stroop TaskPilot StudiesTotal
Healthy volunteers — Hispanic or Latino124189106
Healthy volunteers — Not Hispanic or Latino101483811031290
Healthy volunteers — Unknown or Not Reported2201822
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Sub-study A: Working Memory TaskSub-study C: Sustained Attention to Response Task (SART)Sub-study D: Stroop TaskPilot StudiesTotal
Healthy volunteers — American Indian or Alaska Native00077
Healthy volunteers — Asian2273169201
Healthy volunteers — Native Hawaiian or Other Pacific Islander00033
Healthy volunteers — Black or African American262013280339
Healthy volunteers — White582321662764
Healthy volunteers — More than one race6112634
Healthy volunteers — Unknown or Not Reported3316370
08

Study locations

1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892, United States
09

References and documents

Publications

  • Grillon C, Morgan CA 3rd. Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol. 1999 Feb;108(1):134-42. doi: 10.1037//0021-843x.108.1.134. PubMed 10066999 ↗
  • Grillon C, Ameli R, Goddard A, Woods SW, Davis M. Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry. 1994 Apr 1;35(7):431-9. doi: 10.1016/0006-3223(94)90040-x. PubMed 8018793 ↗
  • Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992 Apr;106(2):274-85. doi: 10.1037//0735-7044.106.2.274. PubMed 1590953 ↗
  • Balderston NL, Liu J, Roberson-Nay R, Ernst M, Grillon C. The relationship between dlPFC activity during unpredictable threat and CO2-induced panic symptoms. Transl Psychiatry. 2017 Nov 30;7(12):1266. doi: 10.1038/s41398-017-0006-5. PubMed 29213110 ↗
  • Grillon C, Robinson OJ, Krimsky M, O'Connell K, Alvarez G, Ernst M. Anxiety-mediated facilitation of behavioral inhibition: Threat processing and defensive reactivity during a go/no-go task. Emotion. 2017 Mar;17(2):259-266. doi: 10.1037/emo0000214. Epub 2016 Sep 19. PubMed 27642657 ↗
  • Grillon C, Robinson OJ, Mathur A, Ernst M. Effect of attention control on sustained attention during induced anxiety. Cogn Emot. 2016;30(4):700-12. doi: 10.1080/02699931.2015.1024614. Epub 2015 Apr 22. PubMed 25899613 ↗
  • Lago TR, Hsiung A, Leitner BP, Duckworth CJ, Balderston NL, Chen KY, Grillon C, Ernst M. Exercise modulates the interaction between cognition and anxiety in humans. Cogn Emot. 2019 Jun;33(4):863-870. doi: 10.1080/02699931.2018.1500445. Epub 2018 Jul 23. PubMed 30032703 ↗
  • Grillon C, Ernst M. A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans. Neurosci Biobehav Rev. 2020 Dec;119:348-354. doi: 10.1016/j.neubiorev.2020.09.024. Epub 2020 Oct 7. PubMed 33038346 ↗
  • Grillon C, Lago T, Stahl S, Beale A, Balderston N, Ernst M. Better cognitive efficiency is associated with increased experimental anxiety. Psychophysiology. 2020 Aug;57(8):e13559. doi: 10.1111/psyp.13559. Epub 2020 Mar 17. PubMed 32180239 ↗
  • Sarigiannidis I, Grillon C, Ernst M, Roiser JP, Robinson OJ. Anxiety makes time pass quicker while fear has no effect. Cognition. 2020 Apr;197:104116. doi: 10.1016/j.cognition.2019.104116. Epub 2019 Dec 26. PubMed 31883966 ↗
  • Robinson OJ, Pike AC, Cornwell B, Grillon C. The translational neural circuitry of anxiety. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1353-1360. doi: 10.1136/jnnp-2019-321400. Epub 2019 Jun 29. PubMed 31256001 ↗
  • Balderston NL, Hsiung A, Liu J, Ernst M, Grillon C. Reducing State Anxiety Using Working Memory Maintenance. J Vis Exp. 2017 Jul 19;(125):55727. doi: 10.3791/55727. PubMed 28745646 ↗
  • Lago T, Davis A, Grillon C, Ernst M. Striatum on the anxiety map: Small detours into adolescence. Brain Res. 2017 Jan 1;1654(Pt B):177-184. doi: 10.1016/j.brainres.2016.06.006. Epub 2016 Jun 6. PubMed 27276526 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 25, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — We will provide de-identified data to repositories but no identifiable data.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00026559
Lead sponsor
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Nov 12, 2001
Start date
Jan 10, 2001
Primary completion
Jul 28, 2022
Completion
Jul 28, 2022
Results posted
Jan 9, 2024
Last update
Jan 9, 2024

Study contacts

Maryland Pao, M.D.
principal investigator · National Institute of Mental Health (NIMH)

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion